Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$1.27 - $2.06 $50 - $82
-40 Reduced 5.71%
660 $1,000
Q3 2023

Nov 07, 2023

BUY
$1.8 - $3.61 $1,260 - $2,527
700 New
700 $1,000
Q3 2021

Oct 26, 2021

SELL
$10.11 - $17.56 $1,607 - $2,792
-159 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$14.9 - $20.82 $2,369 - $3,310
159 New
159 $2,000
Q1 2021

Apr 26, 2021

SELL
$12.57 - $21.22 $553 - $933
-44 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$8.73 - $14.56 $365,996 - $610,413
-41,924 Reduced 99.9%
44 $0
Q3 2020

Oct 27, 2020

BUY
$8.56 - $11.6 $175,240 - $237,475
20,472 Added 95.24%
41,968 $369,000
Q1 2020

May 07, 2020

BUY
$6.94 - $14.42 $149,182 - $309,972
21,496 New
21,496 $157,000
Q4 2019

Feb 06, 2020

SELL
$6.23 - $7.98 $32,402 - $41,503
-5,201 Closed
0 $0
Q3 2019

Oct 28, 2019

BUY
$5.62 - $7.86 $29,229 - $40,879
5,201 New
5,201 $35,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $30.1M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.